ARTICLE | Company News
Athersys gains on deal with Pfizer
December 22, 2009 1:47 AM UTC
Athersys Inc. (NASDAQ:ATHX) jumped $1.40 (140%) to $2.40 on Monday after granting Pfizer Inc. (NYSE:PFE) rights to develop and commercialize MultiStem to treat inflammatory bowel disease (IBD). The th...